Concepedia

Craig I Coleman

CI

Statistics

Publications

145

Citations

5.4K

H-Index

40

Active since

2002

Affiliations

University of Connecticut(Current)

Hartford Hospital

Hartford Financial Services (United States)

Janssen (United States)

Janssen Scientific Affairs (United States)

Craig I Coleman is an author at University of Connecticut specializing in medicine, cardiovascular disease, and anesthesiology.

ORCID

Top concepts

Publications per year

2002–2024

145

Publications

145

The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes

Effie L. Gillespie, C Michael White, Michael J. Kardas et al. · Diabetes Care · 2005 · 220 citations · Full text

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

François Laliberté, Michel Cloutier, Winnie W. Nelson et al. · Current Medical Research and Opinion · 2014 · 185 citations

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

Elizabeth S. Mearns, Diana M Sobieraj, C Michael White et al. · PLoS ONE · 2015 · 141 citations · Full text

Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Soyon Lee, Moise Anglade, Robyn Pisacane et al. · The American Journal of Cardiology · 2012 · 128 citations

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis

Craig I Coleman, Reinhold Kreutz, Nitesh Sood et al. · The American Journal of Medicine · 2019 · 119 citations

, , +10

1–5 of 145